IMMUNIC, INC. — Director's Dealing 2014

Apr 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-04-23

Reporting Person: Satter Muneer A (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-23	Common Stock	C	6140402	—	Acquired	6282519	Indirect
2014-04-23	Common Stock	P	360966	$12.00	Acquired	6643485	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-23	Convertible Preferred Stock	$	C	2589764	Disposed		Common Stock (2589764)	Indirect
2014-04-23	Senior Convertible Preferred Stock	$	C	3550638	Disposed		Common Stock (3550638)	Indirect

Footnotes

F1: Upon the closing of the Issuer's initial public offering, each share of Convertible Preferred Stock automatically converted into Common Stock on a one-for-one basis without payment of further consideration. Each share of Convertible Preferred Stock was previously convertible at any time at the election of the Reporting Person and there was no expiration date.

F2: Upon the closing of the Issuer's initial public offering, each share of Senior Convertible Preferred Stock automatically converted into Common Stock on a one-for-one basis without payment of further consideration. Each share of Senior Convertible Preferred Stock was previously convertible at any time at the election of the Reporting Person and there was no expiration date.

F3: Includes (a) 4,026,878 shares that are held by Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares and (b) 2,255,641 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clause (b) of this footnote (3), except to the extent of his pecuniary interest.

F4: All shares were purchased in connection with the Issuer's initial public offering.

F5: Includes (a) 4,159,344 shares that are held by Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares and (b) 2,514,141 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clause (b) of this footnote (5), except to the extent of his pecuniary interest.

F6: Includes (a) 1,838,106 shares that are held by Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares and (b) 751,658 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clause (b) of this footnote (6), except to the extent of his pecuniary interest.

F7: Includes (a) 2,155,615 shares that are held by Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares and (b) 1,395,023 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clause (b) of this footnote (7), except to the extent of his pecuniary interest.